Skip to primary content
Skip to secondary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Tag Archives: CAM

CAM Use in Functional Abdominal Pain

Posted on January 1, 2021 by gutsandgrowth
From Journal of Pediatrics Twitter Feed

SL Ciciora et al. J Pediatr 2020; 227: 53-59. Complementary and Alternative Medicine Use in Pediatric Functional Abdominal Pain Disorders at a Large Academic Center

Related blog posts:

  • It Can’t Hurt Right? Complementary and Alternative Medicine and Gluten-Related Disorders
  • “No Solid Conclusions” for Alternative/Complementary Medicine in IBD
Posted in Pediatric Gastroenterology Intestinal Disorder | Tagged abdominal pain, CAM, complementary alternative medicine

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Top Posts & Pages

  • Expert Practice Recommendations for C difficile Infection in Adults
  • Get Ready for 2021 Coding Changes
  • Dupilumab Rarely Associated with Pediatric Neuroinflammatory and Neuropsychiatric Symptoms
  • GI Bleeding -Forrest Classification
  • More Data Supporting Lactated Ringers for Acute Pancreatitis
  • Dr. Stacy Kahn: Clostridioides difficile 2026
  • How to Score the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Properly
  • Pictographic Constipation Action Plan
  • Identifying Biliary Atresia in Infants: New Guidelines
  • PODIUM Study: Jak Inhibitors and Ustekinumab Outperformed Vedolizumab as a 2nd Line Agent for Ulcerative Colitis

Log-In

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Recent Posts

  • Expert Practice Recommendations for C difficile Infection in Adults
  • Dupilumab Rarely Associated with Pediatric Neuroinflammatory and Neuropsychiatric Symptoms
  • Incredible Video of Lung Cell Cilia
  • Adherence to a Gluten Free Diet in Pediatric Celiac Disease
  • Promising Pilot Study Using Substance P to Screen for Pediatric Aspiration
  • Impact of Night Shifts on Gut Disorders
  • PODIUM Study: Jak Inhibitors and Ustekinumab Outperformed Vedolizumab as a 2nd Line Agent for Ulcerative Colitis
Blog at WordPress.com.
  • Subscribe Subscribed
    gutsandgrowth
    Join 1,031 other subscribers

    Have a WordPress.com account? Log in now.

  • gutsandgrowth
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...